Form 4 for AFRM Affirm Holdings, Inc.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001628280-24-040854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-18 | 2024-09-16+ | AFRM | Adkins Katherine | CLO | M - OptEx | $8.80 | +100.0K | 168.7K | +146% | +$880.0K |
| DM | 2024-09-18 | 2024-09-16+ | AFRM | Adkins Katherine | CLO | S - Sale+OE | $45.00 | -135.0K | 122.1K | -53% | -$6.08M |
| DM | 2024-09-18 | 2024-09-16+ | AFRM | Adkins Katherine | CLO | M - OptEx | $0.00 | -100.0K | 28.0K | -78% | $0 |
| DM | 2024-09-18 | 2024-09-16 | AFRM | Adkins Katherine | CLO | A - Grant | $0.00 | +95.7K | 55.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-09-16 | M | A | 1,654 | $8.80 | 128,153 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. |
| 2 | Common | Class A Common Stock | 2024-09-18 | S | D | 82,316 | $45.00 | 91,499 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. (F3) Represents the weighted average sale price of the shares sold from $45.00 to $45.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Class A Common Stock | 2024-09-18 | M | A | 51,746 | $8.80 | 173,815 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. |
| 4 | Common | Class A Common Stock | 2024-09-16 | S | D | 6,084 | $45.00 | 122,069 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. |
| 5 | Common | Class A Common Stock | 2024-09-17 | M | A | 46,600 | $8.80 | 168,669 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. |
| 6 | Common | Class A Common Stock | 2024-09-17 | S | D | 46,600 | $45.00 | 122,069 | D | — | — | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. (F2) Represents the weighted average sale price of the shares sold from $45.00 to $45.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-09-16 | M | D | 1,654 | $0.00 | 126,346 | D | $8.80 · — to 2029-10-14 | 1,654 Class A Common Stock | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. (F7) The stock options vested as to 25% of the underlying shares on September 14, 2020, and the remainder vested in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-09-17 | M | D | 46,600 | $0.00 | 79,746 | D | $8.80 · — to 2029-10-14 | 46,600 Class A Common Stock | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. (F7) The stock options vested as to 25% of the underlying shares on September 14, 2020, and the remainder vested in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-09-18 | M | D | 51,746 | $0.00 | 28,000 | D | $8.80 · — to 2029-10-14 | 51,746 Class A Common Stock | (F1) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024. (F7) The stock options vested as to 25% of the underlying shares on September 14, 2020, and the remainder vested in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 10 | Derivative | Restricted Stock Units | 2024-09-16 | A | A | 39,718 | $0.00 | 39,718 | D | — · — to — | 39,718 Class A Common Stock | (F4) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F5) The RSUs vest as to 25% of the shares on September 1, 2025 and the remainder vest in 12 equal quarterly installments over the subsequent three years, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-09-16 | A | A | 55,946 | $0.00 | 55,946 | D | $44.06 · — to 2034-09-16 | 55,946 Class A Common Stock | (F6) The stock options vest as to 25% of the underlying shares on September 1, 2025 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |